economic evaluation of an asthma therapy: effect of salmeterol on loss of labor productivity in japan

Clicks: 286
ID: 207759
2005
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #32 of 108 articles by views in current drug discovery technologies

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Background: Asthma can have a negative impact on the productivity of paid and unpaid individuals. In this study, we aimed to investigate the impact of salmeterol, which, in recent years, has become available for the treatment of asthma in Japan, on the productivity of patients with asthma. Methods: Relevant data were extracted from the medical records of 54 patients aged ≥15 years with moderate or severe asthma. Loss of productivity was estimated via the human capital approach in the year before and the year after introduction of salmeterol. Results: Lost productivity was significantly reduced (p < 0.001) after salmeterol's introduction compared to the period before its introduction in both paid labors and unpaid ones. Reduced loss of productivity avoided loss of approximately 800,000 yen in the paid ones and 61.3 days in unpaid ones. It was estimated that loss of about 105.4 billion yen in the paid group and 64.5 billion yen in the unpaid group could be avoided if this result was expanded to the wider society. In paid labors, productivity loss was avoided when symptoms were absent during the day, irrespective of the presence or absence of symptoms during the night, whereas, in the unpaid group, the loss was avoided when symptoms were absent during the day or night. Conclusions: It was considered that improvement of clinical symptoms, which occurred in association with the introduction of salmeterol, resulted in avoidance of losses in productivity that had previously occurred in patients with asthma.
Reference Key
miyagawa2005allergologyeconomic Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Takehiko Miyagawa;Shuzo Nishimura
Journal current drug discovery technologies
Year 2005
DOI
10.2332/allergolint.54.461
URL
http://www.sciencedirect.com/science/article/pii/S1323893015310595
Keywords
asthma economics productivity allergy

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.